`
`· · · · · · · ·BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`· · · · · · · - - - - - - - - - - - - - - - - - - - - -
`
`· · · · · · · · · · THERMO FISHER SCIENTIFIC INC.
`
`· · · · · · · · · · · · · · ·Petitioner,
`
`· · · · · · · · · · · · · · · · ·v.
`
`· · · · · · · · · · ·BIO-RAD LABORATORIES, INC.
`
`· · · · · · · · · · · · · · Patent Owner.
`
`· · · · · · · - - - - - - - - - - - - - - - - - - - - -
`
`· · · · · · · ·Case IPR2017-00054 (Patent 8,236,504)
`· · · · · · · ·Case IPR2017-00055 (Patent 8,236,504)
`·
`
`· · · · · · · ·Videotaped deposition of DEAN P. NEIKIRK,
`
`· · ·PH.D., taken pursuant to Notice, was held at the Law
`
`· · ·Offices of JONES DAY, 250 Vesey Street, New York, New
`
`· · ·York, commencing August 22, 2017, 9:06 a.m., on the
`
`· · ·above date, before Amanda McCredo, a Court Reporter and
`
`· · ·Notary Public in the State of New York.
`
`·
`· · · · · · · · · · · · · ·- - -
`·
`
`·
`
`·
`
`·
`
`·
`
`·
`
`·
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 1 of 145
`
`
`
`·1· ·A P P E A R A N C E S:
`
`·2· ·MORRIS, NICHOLS, ARSHT & TUNNELL, LLP
`· · · · · · · · · 1201 North Market Street
`·3· · · · · · · · Suite 1800
`· · · · · · · · · Wilmington, Delaware 19801
`·4· ·BY: BRIAN EGAN, ESQ.
`· · ·began@mnat.com
`·5· ·(212)227-5000
`· · ·Attorneys for Petitioner
`·6
`
`·7
`
`·8
`
`·9· ·JONES DAY
`· · · · · · · · · 250 Vesey Street
`10· · · · · · · · New York, New York 10281
`· · ·BY: KELSEY I. NIX, ESQ.
`11· ·knix@jonesday.com
`· · ·(212)326-3939
`12· ·Attorneys for Patent Owner
`
`13
`
`14
`
`15· ·ALSO PRESENT:
`
`16· ·Sean Boyle - In-house counsel at Thermo Fisher
`
`17· ·Adam Nicolais, Esq. - Jones Day
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 2 of 145
`
`
`
`·1· · · · · · · · · · · · I N D E X
`
`·2· ·WITNESS· · · · · · ·EXAMINATION BY· · · · · · · PAGE
`
`·3· ·Dean P. Neikirk· · ·Mr. Egan· · · · · · · · · · · 5
`
`·4
`
`·5· · · · · · · · · · · · ·EXHIBITS
`
`·6· ·EXHIBIT· · · · · · · · · · · · · · · · · · · · ·PAGE
`
`·7· ·Exhibit 1· · ·Declaration Under 37 C.F.R.· · · ·120
`· · · · · · · · · ·Section 1.132 by Paul J. Patt
`·8
`
`·9
`
`10· · · · · · · · · PREVIOUSLY MARKED EXHIBITS
`
`11· ·EXHIBIT· · · · · · · · · · · · · · · · · · · · ·PAGE
`
`12· ·Bio-Rad 2001· · · · · · · · · · · · · · · · · · ·22
`
`13· ·Bio-Rad 2003· · · · · · · · · · · · · · · · · · ·22
`
`14· ·Thermo Fisher 1001· · · · · · · · · · · · · · · ·24
`
`15· ·Thermo Fisher 1005· · · · · · · · · · · · · · · ·69
`
`16· ·Thermo Fisher 1006· · · · · · · · · · · · · · · ·83
`
`17· ·Thermo Fisher 1009· · · · · · · · · · · · · · · ·89
`
`18· ·Thermo Fisher 1004· · · · · · · · · · · · · · · 107
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 3 of 145
`
`
`
`·1· · · · · · THE VIDEOGRAPHER:· This is the videotaped
`
`·2· · · · deposition of Dr. Dean Neikirk in the matter of
`
`·3· · · · Thermo Fisher Scientific Inc. v Bio-Rad
`
`·4· · · · Laboratories, Inc.
`
`·5· · · · · · This deposition is being held at Jones Day
`
`·6· · · · on August 22, 2017.
`
`·7· · · · · · My name is Charlie Bowen from U.S. Legal
`
`·8· · · · Support, and I am the video specialist.· The
`
`·9· · · · court reporter today is Amanda McCredo, also
`
`10· · · · from U.S. Legal Support.
`
`11· · · · · · We are going on the record at 9:06 a.m.
`
`12· · · · · · Counsel, please state your appearances for
`
`13· · · · the record.
`
`14· · · · · · MR. NIX:· Kelsey Nix for the patent owner,
`
`15· · · · Bio-Rad, and for the witness, from Jones Day.
`
`16· · · · · · And with me today is associate Adam
`
`17· · · · Nicolais.
`
`18· · · · · · MR. EGAN:· Brian Egan on behalf of
`
`19· · · · petitioner, Thermo Fisher, from the Morris,
`
`20· · · · Nichols, Arsht & Tunnell law firm.
`
`21· · · · · · With me today is Sean Boyle, who is
`
`22· · · · in-house counsel with Thermo Fisher.
`
`23· · · · · · THE VIDEOGRAPHER:· Will the court reporter
`
`24· · · · please swear in the witness.
`
`25· ·D E A N· ·N E I K I R K, the witness herein, after
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 4 of 145
`
`
`
`·1· · · · · · ·having been first duly sworn by a Notary
`
`·2· · · · · · ·Public of the State of New York, was
`
`·3· · · · · · ·examined and testified as follows:
`
`·4· ·EXAMINATION BY
`
`·5· ·MR. EGAN:
`
`·6· · · ·Q· · Good morning, Dr. Neikirk.
`
`·7· · · ·A· · Good morning.
`
`·8· · · ·Q· · Can you please state your full name and
`
`·9· ·address for the record?
`
`10· · · ·A· · Dean Paul Neikirk of 6604 Auburn Hill,
`
`11· ·Austin, Texas.
`
`12· · · ·Q· · Okay.· And you're appearing here today as
`
`13· ·an expert on behalf of Bio-Rad Laboratories,
`
`14· ·Incorporated in two separate IPR proceedings
`
`15· ·involving U.S. Patent 8,236,504, correct?
`
`16· · · ·A· · That is correct.
`
`17· · · ·Q· · Okay.· And you've referred to that patent
`
`18· ·in your analysis as the '504 patent or the 504
`
`19· ·patent?
`
`20· · · ·A· · Yes, that's correct.
`
`21· · · ·Q· · Okay.· Have you ever been deposed before?
`
`22· · · ·A· · I have.
`
`23· · · ·Q· · How many times have you been deposed
`
`24· ·before?
`
`25· · · ·A· · Probably well in excess of 20 times.
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 5 of 145
`
`
`
`·1· · · ·Q· · Okay.· And did any of those matters involve
`
`·2· ·patent disputes?
`
`·3· · · ·A· · They all did, yes.
`
`·4· · · ·Q· · They all did?· Okay.
`
`·5· · · ·A· · Well, I'm trying to think.· Two trade
`
`·6· ·secret cases, I don't even know whether those
`
`·7· ·involved depositions.· But all the rest are patent
`
`·8· ·cases.
`
`·9· · · ·Q· · Okay.· In those 20 or so patent cases, you
`
`10· ·were acting as an expert in each of those cases?
`
`11· · · ·A· · That's correct.
`
`12· · · ·Q· · Okay.· So, you've been through this process
`
`13· ·before, but I'll just go over the basic ground rules
`
`14· ·of depositions.
`
`15· · · · · · First, do you understand that you'll be
`
`16· ·answering questions today under oath?· Correct?
`
`17· · · ·A· · I do understand that, yes.
`
`18· · · ·Q· · Okay.· And if at any time you don't
`
`19· ·understand one of my questions, let me know, and
`
`20· ·I'll do my best to rephrase it until you do
`
`21· ·understand it.
`
`22· · · ·A· · Yes, I'll certainly do that.
`
`23· · · ·Q· · Okay.· You understand that all of your
`
`24· ·answers should be verbal so that we can get it on
`
`25· ·the record, because the court reporter can't take
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 6 of 145
`
`
`
`·1· ·down nonverbal responses, right?
`
`·2· · · ·A· · Yes, I understand that.
`
`·3· · · ·Q· · Okay.· And if you need to take a break at
`
`·4· ·any point, just let me know, and I'll try to find a
`
`·5· ·reasonable stopping point.
`
`·6· · · ·A· · And I'll certainly do that.
`
`·7· · · ·Q· · Okay.· Is there anything that would
`
`·8· ·preclude you from answering truthfully today?
`
`·9· · · ·A· · No, there is not.
`
`10· · · ·Q· · Okay.· In the cases where you have
`
`11· ·previously served as an expert witness, have you
`
`12· ·ever served as an expert witness in cases involving
`
`13· ·real-time PCR technology?
`
`14· · · ·A· · No, I don't think I've done anything on
`
`15· ·real-time PCR specifically.
`
`16· · · ·Q· · Okay.· And when we use the term "real-time
`
`17· ·PCR," what do you understand that to mean?
`
`18· · · ·A· · Well, PCR is a DNA amplification process
`
`19· ·involving temperature cycling; real-time in the
`
`20· ·sense that you're trying to monitor the samples in
`
`21· ·place, as opposed to doing separations with
`
`22· ·something like gel electrophoresis.
`
`23· · · ·Q· · Okay.· And you mentioned gel
`
`24· ·electrophoresis.
`
`25· · · · · · What is the difference between gel
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 7 of 145
`
`
`
`·1· ·electrophoresis and PCR?
`
`·2· · · ·A· · Well, PCR is a method that amplifies DNA,
`
`·3· ·and then you also want to couple that with a method
`
`·4· ·of detecting what DNA is present.
`
`·5· · · · · · Gel electrophoresis is a method of
`
`·6· ·separating the DNA, based on its mass, into bands.
`
`·7· ·It's kind of the old way to do it, as opposed to
`
`·8· ·techniques which, for instance, use a fluorescent
`
`·9· ·labeling technique, which would be more amenable to
`
`10· ·so-called real-time analysis.
`
`11· · · ·Q· · Okay.· So, is it fair to say that in an
`
`12· ·electrophoresis process, the sample is already
`
`13· ·complete, there is no further reaction being
`
`14· ·performed?
`
`15· · · ·A· · Yes.· In that case, the PCR, which is the
`
`16· ·technique to amplify the DNA, comes first.· And then
`
`17· ·you do a separations technique to separate the
`
`18· ·different strings by mass.
`
`19· · · ·Q· · Okay.· Fair enough.
`
`20· · · · · · When were you first contacted to serve as
`
`21· ·an expert in this case?
`
`22· · · ·A· · In this case, I think it was about a year
`
`23· ·ago.· I think it's a little bit less than a year.
`
`24· ·But in rough terms, about a year.
`
`25· · · ·Q· · And you were retained through an agency
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 8 of 145
`
`
`
`·1· ·through Teklicon, Incorporated; is that correct?
`
`·2· · · ·A· · That is correct.
`
`·3· · · ·Q· · Okay.· And do you have a relationship with
`
`·4· ·Teklicon?
`
`·5· · · ·A· · I have known the people at Teklicon for
`
`·6· ·many years and have -- they typically contact me if
`
`·7· ·they have a case that they think I might be a good
`
`·8· ·fit for.· I've probably done a couple of other cases
`
`·9· ·through Teklicon over the years.
`
`10· · · ·Q· · Okay.· Are you aware that, in this case,
`
`11· ·Bio-Rad filed what's called a preliminary patent
`
`12· ·office -- or a patent owner's response?
`
`13· · · ·A· · Yes.
`
`14· · · ·Q· · Okay.· Do you know if you were retained
`
`15· ·before or after that response was filed?
`
`16· · · ·A· · I believe it was before.
`
`17· · · ·Q· · Okay.· Do you know if you provided any
`
`18· ·assistance to Bio-Rad in, in writing that
`
`19· ·preliminary response?
`
`20· · · ·A· · If I recall the timeline correctly, I'd
`
`21· ·certainly -- I believe I had reviewed the patents
`
`22· ·that had been asserted against the '504 and had had
`
`23· ·general discussions with counsel about those.
`
`24· · · ·Q· · Okay.· Are you billing hourly for your time
`
`25· ·spent on this matter?
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 9 of 145
`
`
`
`·1· · · ·A· · Yes, I am.
`
`·2· · · ·Q· · And what is your hourly rate?
`
`·3· · · ·A· · My hourly rate is $500 an hour.
`
`·4· · · ·Q· · Can you estimate how much time to date
`
`·5· ·you've spent?
`
`·6· · · ·A· · Probably somewhere around, I guess, maybe
`
`·7· ·80 hours, since we started.· Might be, might be a
`
`·8· ·little bit more than that, a little bit less, but I
`
`·9· ·think that's about the right order of magnitude.
`
`10· · · ·Q· · Okay.· And you've submitted two
`
`11· ·declarations so far, correct?
`
`12· · · ·A· · That's correct.
`
`13· · · ·Q· · Okay.· And did you, yourself, draft those
`
`14· ·two declarations?
`
`15· · · ·A· · So, in both cases, portions of those I
`
`16· ·typed myself, portions I didn't type myself.· But
`
`17· ·they were only done after extensive discussion with
`
`18· ·counsel who was assisting me, where I made it very
`
`19· ·clear what my opinions were, and those are what went
`
`20· ·into the first draft and any subsequent revisions.
`
`21· · · ·Q· · Okay.· Now, without disclosing the content
`
`22· ·of any of your conversations with counsel, what did
`
`23· ·you do to prepare for today's deposition?
`
`24· · · ·A· · I reviewed the petitioner's petitions, I
`
`25· ·reviewed the board's initial response -- I may have
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 10 of 145
`
`
`
`·1· ·the name of that not quite right -- Bio-Rad's
`
`·2· ·replies, my own declarations, Dr. Matthew's
`
`·3· ·declarations, his -- the transcript of his
`
`·4· ·deposition, and all of the prior art that's been at
`
`·5· ·issue.
`
`·6· · · ·Q· · Dr. Neikirk, you hold a degree in
`
`·7· ·mathematics and physics from Oklahoma State; is that
`
`·8· ·correct?
`
`·9· · · ·A· · That's my undergraduate degree, a B.S.,
`
`10· ·yes.
`
`11· · · ·Q· · Okay.· And you also have a master's and a
`
`12· ·Ph.D. degree?
`
`13· · · ·A· · Yes, I do, from the California Institute of
`
`14· ·Technology and Applied Physics.
`
`15· · · ·Q· · And in your declarations, you identify
`
`16· ·yourself as an independent consultant in
`
`17· ·technologies related to sensor systems, including
`
`18· ·those used for biochemical sensing; is that correct?
`
`19· · · ·A· · That's correct.
`
`20· · · ·Q· · Now, what do you mean by, quote, unquote,
`
`21· ·sensor systems?
`
`22· · · ·A· · For the last -- what is it now? -- 38
`
`23· ·years, I have worked on the development of sensors
`
`24· ·of all sorts, ranging from optical sensors to
`
`25· ·infrared sensors to radio wavelength sensors to
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 11 of 145
`
`
`
`·1· ·chemical sensors.· So, a lot of different types of
`
`·2· ·sensor systems.· And that ranges all the way from
`
`·3· ·the fundamental transducer to its integration into a
`
`·4· ·complete system to provide information out the other
`
`·5· ·end.
`
`·6· · · ·Q· · So, when we're talking about real-time PCR
`
`·7· ·technology and sensor systems, is it -- you know,
`
`·8· ·when you say you're an expert in sensor systems, do
`
`·9· ·you mean that you consider yourself an expert on the
`
`10· ·optical components of the real-time PCR technology?
`
`11· · · ·A· · I would say not just the optical
`
`12· ·components; the mechanical systems, the assembly
`
`13· ·into a system.· I have done a lot of work on
`
`14· ·chemical sensors.
`
`15· · · · · · I would not characterize myself as an
`
`16· ·expert -- having enormous expertise on the
`
`17· ·chemistry, specifically.· When I've worked on that,
`
`18· ·I've worked with other biochemists.· But integrating
`
`19· ·their chemistry into a complete system, that's
`
`20· ·typically the part that I coordinated.
`
`21· · · ·Q· · Now, when you reference your limited
`
`22· ·expertise on the chemistry of a real-time PCR
`
`23· ·reaction, does that also include the thermodynamics
`
`24· ·that would be necessary to make that reaction
`
`25· ·happen?
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 12 of 145
`
`
`
`·1· · · ·A· · No, I wouldn't say that.· I've done a lot
`
`·2· ·of work on thermal systems, so I'm very familiar
`
`·3· ·with heat transfer.· I have three years of
`
`·4· ·undergraduate and graduate education in
`
`·5· ·thermodynamics, being a physics and applied physics
`
`·6· ·major.
`
`·7· · · · · · What I would -- what I would say, then, is
`
`·8· ·that I typically don't create new molecules.· That's
`
`·9· ·what my chemistry colleagues do.· I might use the
`
`10· ·molecules they developed, but I don't create the new
`
`11· ·molecules.
`
`12· · · ·Q· · Have you personally ever used a real-time
`
`13· ·PCR machine?
`
`14· · · ·A· · I don't -- I have not personally operated
`
`15· ·one.· There are PCR equipment in the laboratories of
`
`16· ·the chemistry, and biochemistry faculty with whom
`
`17· ·I've collaborated, but I haven't run the machines.
`
`18· · · ·Q· · Okay.· Have you personally ever designed a
`
`19· ·real-time PCR machine?
`
`20· · · ·A· · Again, the systems that I worked on were,
`
`21· ·in many cases, to be alternatives to classical PCR.
`
`22· ·So, no, I haven't built that specific type of
`
`23· ·systems.· I worked on systems we hoped might replace
`
`24· ·them.
`
`25· · · ·Q· · Were there certain shortcomings that you
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 13 of 145
`
`
`
`·1· ·saw in PCR technology as, you know, driving your
`
`·2· ·motivation to design a different type of machine?
`
`·3· · · ·A· · The work that we did, we were hoping to
`
`·4· ·develop handheld, in-home diagnostic systems, which
`
`·5· ·need to be very small and very inexpensive.
`
`·6· · · · · · Now, if, by cost and size, those are
`
`·7· ·disadvantages to PCR, well, not as they're
`
`·8· ·conventionally used they're not.· In the markets
`
`·9· ·that we were interested in, that would have been.
`
`10· ·They're balanced by the fact that they work
`
`11· ·exceedingly well.
`
`12· · · ·Q· · And those handheld devices that you were
`
`13· ·working with, did those involve LED light sources?
`
`14· · · ·A· · They involved LED light sources and other
`
`15· ·light sources, a variety of different sources of
`
`16· ·light.
`
`17· · · ·Q· · Did they include laser light sources?
`
`18· · · ·A· · We had -- we looked at lasers, we looked at
`
`19· ·LEDs, we looked at arc lamps.· Many of the systems
`
`20· ·that we put together as benchtop models used arc
`
`21· ·lamps.
`
`22· · · ·Q· · And the work that you're referring to on
`
`23· ·these handheld devices, did that occur prior to May
`
`24· ·of 2003?
`
`25· · · ·A· · Prior to May 2003 -- I think we started on
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 14 of 145
`
`
`
`·1· ·that, I believe, in the mid '90s and continued
`
`·2· ·working on that until the 2005 to 2010 frame --
`
`·3· ·timeframe, roughly.
`
`·4· · · ·Q· · Are there any PCR machines that you're
`
`·5· ·personally aware of that were commercially available
`
`·6· ·prior to May of 2003?
`
`·7· · · ·A· · That I personally used, no.
`
`·8· · · · · · But in that timeframe, I do a lot of work
`
`·9· ·with micromechanical systems, and certainly was
`
`10· ·aware of efforts to reduce thermal mass in the
`
`11· ·thermal cycling modules.· That was a big push in the
`
`12· ·'90s into the 2000s.
`
`13· · · · · · So, certainly was aware that the machines
`
`14· ·existed.· I wasn't using them personally at that
`
`15· ·time.
`
`16· · · ·Q· · Okay.· And what do you mean by "efforts to
`
`17· ·reduce thermal mass"?
`
`18· · · ·A· · Well, PCR requires temperature cycling up
`
`19· ·and down.· And the speed at which you can heat and
`
`20· ·cool depends on the thermal mass of the entire
`
`21· ·system that you heat and cool.· And there was a lot
`
`22· ·of interest in trying to reduce that thermal mass to
`
`23· ·increase the speed, the cycling time.
`
`24· · · ·Q· · Okay.· And that interest existed prior to
`
`25· ·May of 2003?
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 15 of 145
`
`
`
`·1· · · ·A· · I believe it's -- yes, it certainly did.
`
`·2· · · ·Q· · Now, one component of a real-time PCR
`
`·3· ·machine is a thermal cycler, correct?
`
`·4· · · ·A· · Yeah.· That's one of the generic terms
`
`·5· ·that's used, yes.
`
`·6· · · ·Q· · Okay.· What is your understanding of what a
`
`·7· ·thermal cycler is?
`
`·8· · · ·A· · Well, I think, both generally and in the
`
`·9· ·context of the '504 patent, the thermal cycler
`
`10· ·usually refers to the part of the system which you
`
`11· ·heat -- that contains heaters and coolers, if
`
`12· ·necessary, and the other elements, the samples
`
`13· ·themselves, that you're trying to heat and cool.
`
`14· · · · · · And broadly speaking, I think a lot of
`
`15· ·people tend to refer to that as the thermal control
`
`16· ·module for the PCR.
`
`17· · · ·Q· · Are you aware of any thermal cyclers in
`
`18· ·which the heating component for the thermal cycler
`
`19· ·is positioned below the sample wells?
`
`20· · · ·A· · I think it's very common to use a -- in a
`
`21· ·thermal cycler, for instance, a thermoelectric
`
`22· ·cooler that would be, the samples would be clamped,
`
`23· ·attached to that module.· It could be below it, it
`
`24· ·could be in some other configuration, depending on
`
`25· ·how you arrange the rest of the system.
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 16 of 145
`
`
`
`·1· · · ·Q· · Now, is it fair to say that a thermal
`
`·2· ·cycler is not a thermal cycler until it's connected
`
`·3· ·electrically to a component that can provide power
`
`·4· ·to heat and cool the thermal cycler?
`
`·5· · · ·A· · I don't -- no, I don't think I would view
`
`·6· ·it that way.· I think the object would be called the
`
`·7· ·thermal cycler.· Whether it's performing thermal
`
`·8· ·cycling at any instant in time, obviously it has to
`
`·9· ·be provided energy to heat and cool.· But I think
`
`10· ·people would refer to the thing that has -- where
`
`11· ·its intent, that's what it's going to be used for,
`
`12· ·is a thermal cycling module.
`
`13· · · ·Q· · Have you personally ever used just a
`
`14· ·thermal cycler as opposed to a real-time PCR
`
`15· ·machine?
`
`16· · · ·A· · Absolutely.· We do a lot of testing of
`
`17· ·devices that require measuring data as a function of
`
`18· ·temperature, and those are thermal cyclers.
`
`19· · · ·Q· · And have you personally ever designed a
`
`20· ·thermal cycler?
`
`21· · · ·A· · Yes, I have.· Much of my research,
`
`22· ·especially in the '80s, but it's continued since,
`
`23· ·involves devices that are fundamentally thermal
`
`24· ·devices.· And so, we look at all the heat transport
`
`25· ·issues, self-heating, external heating, all the
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 17 of 145
`
`
`
`·1· ·conduction and convention and transport -- thermal
`
`·2· ·mechanisms.
`
`·3· · · · · · So, yeah, both myself and my graduate
`
`·4· ·students built our own temperature controllers and
`
`·5· ·temperature control modules.
`
`·6· · · ·Q· · Okay.· So, for that work, you weren't, you
`
`·7· ·know, pulling off the shelf a thermal cycler and
`
`·8· ·then incorporating it into the designs that you were
`
`·9· ·working with?
`
`10· · · ·A· · In some of our test equipment, we were
`
`11· ·using an off-the-shelf temperature control module
`
`12· ·thermal cycler.· In other cases, we built them
`
`13· ·ourselves.
`
`14· · · ·Q· · What thermal cyclers are you aware of that
`
`15· ·were commercially available prior to May of 2003?
`
`16· · · ·A· · Gee, I don't recall specific brand names
`
`17· ·right now, as I sit here.
`
`18· · · ·Q· · Now, in the thermal cyclers that you would
`
`19· ·have used prior to May of 2003, have you ever taken
`
`20· ·one of those thermal cyclers and turned it upside
`
`21· ·down and tried to operate it?
`
`22· · · ·A· · So, for some of our work, we probably
`
`23· ·oriented it in all sorts of different positions
`
`24· ·because of the way we were using it.
`
`25· · · · · · I can remember one system where we, where
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 18 of 145
`
`
`
`·1· ·we were doing our work sort of -- I don't know how
`
`·2· ·to describe it.· You said upside down.· Then let's
`
`·3· ·call it vertical -- vertically (indicating) -- it's
`
`·4· ·a hand motion, which she can't get -- up and down.
`
`·5· · · · · · So, I've used heating blocks that were
`
`·6· ·above the sample, below the sample, to either side
`
`·7· ·of the sample, depending on what the rest of the
`
`·8· ·system needed to do.
`
`·9· · · ·Q· · And you said you've used heating blocks
`
`10· ·that were above the sample, below the sample, to
`
`11· ·either side of the sample, depending on what the
`
`12· ·rest of the system needed to do.
`
`13· · · · · · In the positioning of those heating blocks,
`
`14· ·in what orientation were the samples themselves?
`
`15· · · ·A· · So, I don't know exactly how to describe
`
`16· ·it.
`
`17· · · · · · In most cases, the samples were something
`
`18· ·that you might view as approximately -- let's call
`
`19· ·it like a flat sheet, like a business card.· And
`
`20· ·typically, the area of contact, thermal contact
`
`21· ·between the sample and the temperature control
`
`22· ·module or thermal control module is important, so
`
`23· ·they would be face to face, if you will.
`
`24· · · · · · That's the best I think I can describe it.
`
`25· · · ·Q· · Were any of the samples that you were
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 19 of 145
`
`
`
`·1· ·testing liquid samples?
`
`·2· · · ·A· · So, for some of that work, there were
`
`·3· ·liquids.· In other cases, they were PEG polystyrene
`
`·4· ·beads, which are hydrated.· In other cases, they
`
`·5· ·were solids.· And in some cases, they were gases.
`
`·6· ·So, pretty much all of the -- all phases of matter.
`
`·7· · · ·Q· · In those instances where you were using a
`
`·8· ·liquid sample, prior to May of 2003, can you recall
`
`·9· ·any instances where you would have turned that
`
`10· ·liquid sample upside down?
`
`11· · · ·A· · So, in most of those cases, they were --
`
`12· ·so, if -- I don't know what you mean by "upside
`
`13· ·down."· So, if you mean are the liquids below the
`
`14· ·heater?
`
`15· · · · · · So, let me try to get a clarification of
`
`16· ·what "upside down" means.
`
`17· · · ·Q· · Sure.
`
`18· · · · · · Now, in thermal cyclers, for example, there
`
`19· ·are oftentimes sample tubes that are used with
`
`20· ·those, correct?
`
`21· · · ·A· · Yes.
`
`22· · · ·Q· · Okay.· And is it fair to say that a sample
`
`23· ·tube has an opening at the top and, you know, some
`
`24· ·kind of curvature at the bottom to, to hold a liquid
`
`25· ·sample?
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 20 of 145
`
`
`
`·1· · · ·A· · I think that would be pretty common for a
`
`·2· ·sample or -- a sample vessel, yes.
`
`·3· · · ·Q· · Okay.· So, in terms of my questions, if you
`
`·4· ·assume that where the opening is at the top is the
`
`·5· ·top of the sample tube --
`
`·6· · · ·A· · Okay.
`
`·7· · · ·Q· · -- and where the sample is positioned at
`
`·8· ·the bottom of the sample tube would be the bottom of
`
`·9· ·that tube, are there any instances in which you were
`
`10· ·running thermal cycling operations where you turned
`
`11· ·that sample tube upside down?
`
`12· · · ·A· · So, certainly, in most cases, we did not.
`
`13· ·In some cases, we were doing work where capillary
`
`14· ·forces were the dominant force on the liquid.· And
`
`15· ·in those cases, we turned them in all directions.
`
`16· · · · · · In some cases, where there was mixing, we
`
`17· ·might well have a capped tube, and that tube might
`
`18· ·have been rotated.· And so, at some points, it might
`
`19· ·have been upside down.· But when coupled to the
`
`20· ·thermal system, I'd say the most common would put
`
`21· ·the open end up.
`
`22· · · · · · But again, as I said, there were some
`
`23· ·systems that we worked on where we turned them
`
`24· ·sideways or upside down.
`
`25· · · ·Q· · Are you aware of any real-time PCR machines
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 21 of 145
`
`
`
`·1· ·available prior to May of 2003 that could be
`
`·2· ·operated both right-side up and upside down?
`
`·3· · · ·A· · I don't know whether there were or were
`
`·4· ·not.
`
`·5· · · ·Q· · I'm going to hand you a couple of exhibits,
`
`·6· ·so we can use them as reference points.· And all of
`
`·7· ·these exhibits have been previously marked in the
`
`·8· ·IPR proceedings.
`
`·9· · · · · · I'll hand you, first, what's previously
`
`10· ·been marked Bio-Rad Exhibit 2001 in the
`
`11· ·IPR 2017-00054.
`
`12· · · · · · I'm also going to hand you what's
`
`13· ·previously been marked as Thermo Fisher 1001 in what
`
`14· ·I'll call the '054 petition, and this is United
`
`15· ·States Patent 8,236,504 to Kordunsky, et al.
`
`16· · · · · · And I'm also going to hand you what's been
`
`17· ·marked Bio-Rad Exhibit 2003 in IPR2017-00055.
`
`18· · · · · · And again, we'll just shorten that as the
`
`19· ·'055 petition, if that's okay.
`
`20· · · ·A· · Okay.
`
`21· · · ·Q· · So, I'd like to start by looking at Bio-Rad
`
`22· ·Exhibit 2003 from the '055 petition, which is titled
`
`23· ·"Declaration of Dean P. Neikirk, Ph.D., In Support
`
`24· ·of Patent Owner's Response to Petition for Inter
`
`25· ·Partes Review."
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 22 of 145
`
`
`
`·1· · · · · · Do you have that?
`
`·2· · · ·A· · I do.
`
`·3· · · ·Q· · Okay.· And is this the declaration,
`
`·4· ·Dr. Neikirk, that you submitted in support of the
`
`·5· ·patent owner's response in the '055 IPR?
`
`·6· · · ·A· · Flipping to make sure all the pages are
`
`·7· ·here.· Yes, it certainly appears to be.
`
`·8· · · ·Q· · Okay.· And if you could turn to the very
`
`·9· ·last page, page 32.
`
`10· · · ·A· · I'm there.
`
`11· · · ·Q· · Is that your signature at the bottom?
`
`12· · · ·A· · It is.
`
`13· · · ·Q· · Okay.· Could you turn to pages 9 -- let's
`
`14· ·start at page 9 of the Exhibit 2003.
`
`15· · · ·A· · Okay, I'm on page 9.
`
`16· · · ·Q· · Okay.· And do you see the section titled,
`
`17· ·"H, Basis of My Opinions and Materials Considered"?
`
`18· · · ·A· · I do.
`
`19· · · ·Q· · Okay.· And in paragraph 25 -- that extends
`
`20· ·across page 10, as well -- you have a list of bullet
`
`21· ·points of documents that you reviewed and considered
`
`22· ·for purposes of forming your opinion, correct?
`
`23· · · ·A· · That's correct.
`
`24· · · ·Q· · Okay.· Does this list constitute the
`
`25· ·universe of what you considered in forming your
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 23 of 145
`
`
`
`·1· ·opinions for this case?
`
`·2· · · ·A· · For the --
`
`·3· · · ·Q· · And let me clarify that.
`
`·4· · · ·A· · Okay.
`
`·5· · · ·Q· · In forming your opinions for the '055 IPR?
`
`·6· · · ·A· · Yes, it is -- that's the list of materials
`
`·7· ·I've considered in forming my opinions for the '55.
`
`·8· · · ·Q· · Okay.· So, for example, you considered the
`
`·9· ·'504 patent, correct?
`
`10· · · ·A· · That's correct.
`
`11· · · ·Q· · And you considered the prosecution history
`
`12· ·of the '504 patent, correct?
`
`13· · · ·A· · Yes, that is correct.
`
`14· · · ·Q· · Okay.· Now, with regards to the prosecution
`
`15· ·history of the '504 patent, did you review the
`
`16· ·entire prosecution history or only excerpts?
`
`17· · · ·A· · I've been through the entire thing.· I've
`
`18· ·concentrated on certain sections, certainly.
`
`19· · · ·Q· · Okay.
`
`20· · · ·A· · It's a large document, as they frequently
`
`21· ·are.
`
`22· · · ·Q· · Okay.· And you also have in front of you
`
`23· ·Thermo Fisher Exhibit 1001, which is the '504
`
`24· ·patent.
`
`25· · · ·A· · Oh, the patent itself, yes, I do.
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 24 of 145
`
`
`
`·1· · · ·Q· · Okay.· And on the cover of the patent, do
`
`·2· ·you see, on the left-hand column, a reference to
`
`·3· ·related U.S. application data?
`
`·4· · · ·A· · Yes, I do.
`
`·5· · · ·Q· · Okay.· And listed there, it says,
`
`·6· ·"Continuation of application No. 11/555,642 filed on
`
`·7· ·November 1st, 2006, now Patent 7,749,736."
`
`·8· · · · · · Do you see that?
`
`·9· · · ·A· · I do.
`
`10· · · ·Q· · Okay.· In forming your opinions that are
`
`11· ·set forth in Bio-Rad Exhibit 2003, did you consider
`
`12· ·application number 11/555,642 and its prosecution
`
`13· ·history?
`
`14· · · ·A· · So, the prosecution -- that's not the
`
`15· ·prosecution history that I was looking at, as I
`
`16· ·stated in my '55 report.
`
`17· · · ·Q· · Okay.
`
`18· · · ·A· · So, it wasn't the 11/555.
`
`19· · · ·Q· · Okay.· So, for purposes of your report, you
`
`20· ·only considered the file history of the '504 patent,
`
`21· ·correct?
`
`22· · · ·A· · Yes.· The one that's labeled there as
`
`23· ·12/827,525.
`
`24· · · ·Q· · Sorry for all the long numbers.
`
`25· · · · · · Now, there's a second application that's
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 25 of 145
`
`
`
`·1· ·listed on the cover of the '50 patent [sic], as
`
`·2· ·well, which is -- it says, "Continuation of
`
`·3· ·application number 10/431,708, filed on May 8, 2003,
`
`·4· ·now patent No. 7,148,043."
`
`·5· · · · · · Do you see that?
`
`·6· · · ·A· · I do.
`
`·7· · · ·Q· · Okay.· And that is not a prosecution
`
`·8· ·history that you reviewed in forming your opinions
`
`·9· ·as set forth in Exhibit 2003 either, correct?
`
`10· · · ·A· · That's correct.· I've looked at the
`
`11· ·'12 patent application.
`
`12· · · ·Q· · Okay.· And I'm sorry, we'll bounce around
`
`13· ·between some of these declarations throughout the
`
`14· ·day, but if we could turn, then, to Bio-Rad
`
`15· ·Exhibit 2001 from the '054 petition.
`
`16· · · ·A· · I have it.
`
`17· · · ·Q· · And I have the same series of questions for
`
`18· ·this as we just stepped through for the '055
`
`19· ·petition.
`
`20· · · · · · Exhibit 2001 is entitled "Declaration of
`
`21· ·Dean P. Neikirk, Ph.D., In Support of Patent Owner's
`
`22· ·Response to Petition for Inter Partes Review."
`
`23· · · · · · Is this the declaration that you submitted
`
`24· ·in support of the patent owner's response in the
`
`25· ·'054 IPR?
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 26 of 145
`
`
`
`·1· · · ·A· · And again, yes, it certainly appears to be.
`
`·2· · · ·Q· · Okay.· And again, turning to the final
`
`·3· ·page, which is page 47 in this declaration, is that
`
`·4· ·your signature that appears on page 47?
`
`·5· · · ·A· · Yes, it is.
`
`·6· · · ·Q· · Okay.· Now, if we could turn to pages 9
`
`·7· ·through 11 of Exhibit 2001.
`
`·8· · · ·A· · Okay, I'm on page 9.
`
`·9· · · ·Q· · And again, in paragraph 25, you list a
`
`10· ·series of bullet points of documents that you
`
`11· ·reviewed and considered for purposes of forming your
`
`12· ·opinions set forth in the declaration, correct?
`
`13· · · ·A· · That's correct.
`
`14· · · ·Q· · And is the same answer true with regards to
`
`15· ·this declaration that, in terms of file histories
`
`16· ·that you reviewed in forming your opinions, you only
`
`17· ·reviewed the file history for the '504 patent?
`
`18· · · ·A· · Yes.· As I've shown in the second bullet,
`
`19· ·it was the 12/827,521 that I reviewed.
`
`20· · · ·Q· · Okay.· And do the bullet points in
`
`21· ·paragraph 25 constitute the entirety of what you
`
`22· ·considered for purposes of forming your opinions in
`
`23· ·support of patent owner's response in the
`
`24· ·'054 patent [sic] owner's -- in the '054 IPR?
`
`25· ·Excuse me.
`
`THERMO FISHER EX. 1050
`
`Agilent Exhibit 1245
`Page 27 of 145
`
`
`
`·1· · · ·A· ·